MedPath

Chung-Ang University

Chung-Ang University logo
🇰🇷South Korea
Ownership
Private, Subsidiary
Established
1918-01-01
Employees
-
Market Cap
-
Website
http://neweng.cau.ac.kr

Clinical Trials

46

Active:1
Completed:20

Trial Phases

4 Phases

Phase 2:2
Phase 3:1
Phase 4:9
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials

Not Applicable
33 (73.3%)
Phase 4
9 (20.0%)
Phase 2
2 (4.4%)
Phase 3
1 (2.2%)

Effects of Daily Eating Duration on Health

Not Applicable
Completed
Conditions
Nutritional and Metabolic Diseases
Body Weight Maintenance
First Posted Date
2023-07-27
Last Posted Date
2023-12-21
Lead Sponsor
Chung-Ang University
Target Recruit Count
34
Registration Number
NCT05964179
Locations
🇰🇷

Chuang-Ang University, Anseong, Gyeonggi-do, Korea, Republic of

BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer

Not Applicable
Completed
Conditions
BRCA Gene Rearrangement
Interventions
Genetic: BRCA 1
Drug: Chemotherapy
First Posted Date
2019-02-12
Last Posted Date
2021-01-27
Lead Sponsor
Chung-Ang University
Target Recruit Count
30
Registration Number
NCT03838406
Locations
🇰🇷

Chung-Ang University College of Medicine, Seoul, Korea, Republic of

DXR Stent for Vascular Healing and Thrombus Formation: OCT Study

Conditions
Coronary Stent Occlusion
Coronary Artery Disease
First Posted Date
2016-10-14
Last Posted Date
2016-10-19
Lead Sponsor
Chung-Ang University
Target Recruit Count
60
Registration Number
NCT02932995
Locations
🇰🇷

Konyang University Hospital, Daejeon, Korea, Republic of

🇰🇷

Jeju National University Hospital, Jeju, Korea, Republic of

🇰🇷

KyungHee University Medical Center, Seoul, Korea, Republic of

and more 3 locations

The Effect of DPP4 Inhibitor on Vasclular Healing

Phase 4
Conditions
Diabetes Mellitus, Type 2
Acute Coronary Syndrome
Interventions
Drug: Non DPP-4 Inhibitor
First Posted Date
2016-06-16
Last Posted Date
2016-06-16
Lead Sponsor
Chung-Ang University
Target Recruit Count
66
Registration Number
NCT02802644
Locations
🇰🇷

Keimyung University Hospital, Daegu, Korea, Republic of

🇰🇷

Chonnam National University Hospital, Gwangju, Korea, Republic of

🇰🇷

Jeju National University Hospital, Jeju, Korea, Republic of

and more 3 locations

Dexamethasone-induced Hiccup in Chemotherapy Patients Treated by Methylprednisolone Rotation

Phase 3
Completed
Conditions
Dexamethasone-induced Hiccup in Chemotherapy
Interventions
First Posted Date
2013-11-01
Last Posted Date
2017-04-28
Lead Sponsor
Chung-Ang University
Target Recruit Count
65
Registration Number
NCT01974024
Locations
🇰🇷

Gyeongsang National University Hospital, Chiram-dong, Jinju-si, Gyeongsangnam-do, Korea, Republic of

🇰🇷

Chungang University Hospital, Dongjak-gu, Seoul, Korea, Republic of

  • Prev
  • 1
  • 2
  • Next

News

Huonslab Completes Enrollment in Phase 1 Trial for Recombinant Hyaluronidase, Eyes 2025 Regulatory Filing

Huonslab has completed patient enrollment in its pivotal Phase 1 clinical trial of HLB3-002 (Hydizyme™), a recombinant human hyaluronidase, with 243 healthy volunteers across four leading South Korean medical centers.

WISH Trial: Integrated Home Services Study for Homebound Older Adults in South Korea

A multicenter, randomized encouragement design trial is underway to assess the impact of Widely Integrated Services in Home (WISH) on homebound older adults.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.